LIN SUE-JEAN 4

4 · Arcutis Biotherapeutics, Inc. · Filed Jun 9, 2026

AI-generated summary of this filing

Updated Jun 10, 2026

Arcutis (ARQT) Director Lin Sue‑Jean Receives RSU/Derivative Award

What Happened

Lin Sue‑Jean, a non‑employee director of Arcutis Biotherapeutics (ARQT), received equity awards on June 5, 2026: 5,778 restricted stock units (RSUs) and 16,667 derivative awards (total 22,445 units). Both awards were granted at $0.00 per share (no cash paid at grant) as compensation for board service. These are grants (not open‑market purchases or sales).

Key Details

Transaction date: June 5, 2026; Filing date (Form 4): June 9, 2026 (timely filed within the two‑business‑day window).
Grants: 5,778 RSUs @ $0.00; 16,667 derivative units @ $0.00. Total units granted: 22,445.
Vesting/settlement: Awards vest on the earlier of the first anniversary of the grant or immediately before the next annual meeting, subject to continued service. The Reporting Person has elected to defer settlement of the RSUs per an RSU Deferral Election adopted Oct 26, 2025.
Shares owned after the transaction: not specified in the provided filing excerpt.
No sales, purchases, or exercises reported here — this is compensation via equity grant.

Context

RSUs and similar derivative awards represent a future right to receive shares if vesting conditions are met; they are compensation and do not represent immediate cash value until settled. The deferral election means settlement of vested RSUs will be delayed per the director’s election.
These grants are routine board compensation and do not indicate an immediate market transaction (no shares were sold or bought in the open market).

Form 4

Period: 2026-06-05

Director

Transactions

Award
Common Stock
[F1]
2026-06-05+5,778→ 32,513 total
Award
Stock Option (right to buy)
[F2]
2026-06-05+16,667→ 16,667 total
Exercise: $21.23Exp: 2036-06-05→ Common Stock (16,667 underlying)

Footnotes (2)

[F1]Represents Restricted Stock Units ("RSUs") granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof, which shall occur on the earlier of the first anniversary of the grant date, June 5, 2026, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date. Upon vesting of the RSUs, the settlement has been deferred by the Reporting Person, pursuant to the terms of the RSU Deferral Election Form adopted on October 26, 2025, maintained by the Company.
[F2]The underlying shares subject to the option vest and become exercisable as to 100% on the earlier of the first anniversary of the grant date, June 5, 2026, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date.

Signature

/s/ Latha Vairavan, as Attorney-in-Fact for Sue-Jean Lin|2026-06-09

1 file